Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-22 Purchase | 2023-12-26 4:29 pm | Elicio Therapeutics Inc. | ELTX | Chudnovsky Yekaterina GKCC LLC Director 10% Owner | 1,213,000 | $5.81 | $7,047,530 | 1,915,639 (Indirect) | View |
| 2021-02-09 Sale(A) | 2022-05-27 4:20 pm | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 159,177 | $16 | $2,546,832 | 1,439,525 (Direct) | View |
| 2021-02-09 Sale(A) | 2022-05-27 4:19 pm | Angion Biomedica Corp. | ANGN | GANZI VICTOR F Director | 246,720 | $16 | $3,947,520 | 823,117 (Direct) | View |
| 2022-05-25 Purchase | 2022-05-27 4:18 pm | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 11,313 | $1.2466 | $14,103 | 1,891,947 (Direct) | View |
| 2022-05-20 Purchase | 2022-05-25 5:58 pm | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 82,200 | $1.2339 | $101,428 | 1,721,457 (Direct) | View |
| 2022-05-19 Purchase | 2022-05-23 7:48 pm | Angion Biomedica Corp. | ANGN | Nissenson Allen Director | 9,383 | $1.1643 | $10,925 | 9,383 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-30 Option Award | 2024-10-02 4:14 pm | N/A 2034-09-30 | Elicio Therapeutics Inc. | ELTX | Connelly Robert CEO, President and Director | 91,600 | $0 | 91,600 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-02 4:13 pm | N/A 2024-09-30 | Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer | 29,800 | $0 | 29,800 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-02 4:12 pm | N/A 2024-09-30 | Elicio Therapeutics Inc. | ELTX | Haqq Christopher See Remarks | 28,200 | $0 | 28,200 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 06:01 am | N/A 2034-02-01 | Elicio Therapeutics Inc. | ELTX | Piekos Brian Chief Financial Officer | 43,225 | $0 | 43,225 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 06:01 am | N/A 2034-02-01 | Elicio Therapeutics Inc. | ELTX | Connelly Robert CEO, President and Director | 225,137 | $0 | 225,137 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 06:01 am | N/A 2034-02-01 | Elicio Therapeutics Inc. | ELTX | Haqq Christopher See Remarks | 28,200 | $0 | 28,200 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 06:01 am | N/A 2034-02-01 | Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer | 30,142 | $0 | 30,142 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:05 pm | N/A 2033-12-28 | Elicio Therapeutics Inc. | ELTX | Nissenson Allen Director | 4,100 | $0 | 4,100 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:05 pm | N/A 2033-12-28 | Elicio Therapeutics Inc. | ELTX | Chudnovsky Yekaterina Director 10% Owner | 4,100 | $0 | 4,100 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:05 pm | N/A 2033-12-28 | Elicio Therapeutics Inc. | ELTX | WILSON KAREN J Director | 4,100 | $0 | 4,100 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:05 pm | N/A 2033-12-28 | Elicio Therapeutics Inc. | ELTX | ADAMS JULIAN Director | 4,100 | $0 | 4,100 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:05 pm | N/A 2033-12-28 | Elicio Therapeutics Inc. | ELTX | Venkatesan Jay Director | 4,100 | $0 | 4,100 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:05 pm | N/A 2033-12-28 | Elicio Therapeutics Inc. | ELTX | Ashe Carol Gail Director | 4,100 | $0 | 4,100 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:05 pm | N/A 2033-12-28 | Elicio Therapeutics Inc. | ELTX | RUFFOLO ROBERT R Director | 4,100 | $0 | 4,100 (Direct) | View |
Ownership | 2023-06-12 5:14 pm | N/A N/A | Elicio Therapeutics Inc. | ELTX | Chudnovsky Yekaterina Director | 0 | $0 | 707,164 (Indirect) | View |
Ownership | 2023-06-12 5:12 pm | N/A N/A | Elicio Therapeutics Inc. | ELTX | Haqq Christopher See Remarks | 0 | $0 | 135,492 (Direct) | View |
Ownership | 2023-06-07 9:53 pm | N/A 2027-12-27 | Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer | 0 | $0 | 90,299 (Direct) | View |
Ownership | 2023-06-07 9:53 pm | N/A 2032-12-06 | Elicio Therapeutics Inc. | ELTX | Segal Assaf Director | 0 | $0 | 4,525 (Direct) | View |
Ownership | 2023-06-07 9:48 pm | N/A 2030-02-20 | Elicio Therapeutics Inc. | ELTX | RUFFOLO ROBERT R Director | 0 | $0 | 17,078 (Direct) | View |
Ownership | 2023-06-07 9:45 pm | N/A 2031-02-01 | Elicio Therapeutics Inc. | ELTX | Matthies Annette Chief Business Officer | 0 | $0 | 82,205 (Direct) | View |
Ownership | 2023-06-07 9:40 pm | N/A 2032-03-31 | Elicio Therapeutics Inc. | ELTX | ADAMS JULIAN Director | 0 | $0 | 51,316 (Direct) | View |
Ownership | 2023-06-07 9:37 pm | N/A N/A | Elicio Therapeutics Inc. | ELTX | Connelly Robert CEO, President and Director | 0 | $0 | 222,033 (Direct) | View |
Ownership | 2023-06-07 9:36 pm | N/A 2032-03-31 | Elicio Therapeutics Inc. | ELTX | Ashe Carol Gail Director | 0 | $0 | 14,909 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:25 pm | N/A 2033-06-01 | Elicio Therapeutics Inc. | ELTX | Piekos Brian Chief Financial Officer | 75,484 | $0 | 75,484 (Direct) | View |
| 2022-07-01 Tax Withholding | 2022-07-11 7:54 pm | N/A N/A | Angion Biomedica Corp. | ANGN | Goldberg Itzhak Director | 32,082 | $1.12 | 1,687,986 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 5:27 pm | N/A 2032-06-09 | Angion Biomedica Corp. | ANGN | GANZI VICTOR F Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 5:26 pm | N/A 2032-06-09 | Angion Biomedica Corp. | ANGN | Nissenson Allen Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 5:26 pm | N/A 2032-06-09 | Angion Biomedica Corp. | ANGN | WILSON KAREN J Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 5:26 pm | N/A 2032-06-09 | Angion Biomedica Corp. | ANGN | OMENN GILBERT S Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-02-09 Exercise(A) | 2022-05-27 4:20 pm | N/A 2028-07-05 | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 396,329 | $0 | 1,439,525 (Direct) | View |
| 2021-02-09 Exercise(A) | 2022-05-27 4:20 pm | N/A N/A | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 396,329 | $6.43 | 1,439,525 (Direct) | View |
| 2021-02-09 Conversion(A) | 2022-05-27 4:20 pm | N/A N/A | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 262 | $11.57 | 1,439,525 (Direct) | View |
| 2021-02-09 Exercise(A) | 2022-05-27 4:19 pm | N/A 2028-07-05 | Angion Biomedica Corp. | ANGN | GANZI VICTOR F Director | 614,310 | $0 | 823,117 (Direct) | View |
| 2021-02-09 Exercise(A) | 2022-05-27 4:19 pm | N/A N/A | Angion Biomedica Corp. | ANGN | GANZI VICTOR F Director | 614,310 | $6.43 | 823,117 (Direct) | View |